Article
Navigating therapeutic challenges in VEXAS syndrome: exploring IL-6 and JAK inhibitors at the forefront.
Molecular medicine (Cambridge, Mass.) - 17 Sept 2024
Li Xiao Xiao, Huang Wen Hui, Yang Xiao Bin, Yang Qi Lin, Zheng Yu, Huo Yong Bao, Xie Ting Ting, Huang Cheng Hui, Yu Shui Lian
Abstract excerpt
VEXAS syndrome, an uncommon yet severe autoimmune disorder stemming from a mutation in the UBA1 gene, is the focus of this paper. The overview encompasses its discovery, epidemiological traits, genetic underpinnings, and clinical presentations. Delving into whether distinct genotypes yield varied clinical phenotypes in VEXAS patients, and the consequent adjustment of treatment strategies based on genotypic and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
